Claims
- 1. A quantitative detection method for quantitatively determining a content ratio of a genetic recombinant in a sample containing at least one genetic recombinant lines, which comprises:
(i) performing quantitative PCR for a DNA sequence specific to the genetic recombinant(s) which may exist in a DNA sample derived from genetic recombinants in the sample and PCR for an endogenous DNA sequence shared by the species corresponding to the genetic recombinant using, as a standard molecule, a molecule containing, on a single molecule, the DNA sequence specific to the genetic recombinant and the endogenous DNA sequence; (ii) determining the number of the DNA sequence specific to the genetic recombinant(s) in the sample based on the result of the quantitative PCR; (iii) determining the number of the endogenous DNA sequence in the sample based on the result of the quantitative PCR; and (iv) determining the content ratio of the genetic recombinant(s) according to formula (I): (content ratio of the genetic recombinant(s) in the sample)=100×[(the number of molecules of the DNA sequence specific to the genetic recombinant(s) in the sample)/(the number of molecules of the endogenous DNA sequence in the sample)]/(quantification ratio)(%) (I) wherein the quantification ratio is any of the values which is pre-calculated according to formula (II): (quantification ratio) (%)=(the number of molecules of the DNA sequence specific to a genetic recombinant from the individual genetic recombinant line)/(the number of molecules of the endogenous DNA sequence in the genetic recombinant) (II).
- 2. A quantitative detection method for quantitatively determining an individual content ratio of an individual genetic recombinant line in a sample containing at lest one genetic recombinant line, which comprises:
(i) performing quantitative PCR for a DNA sequence specific to the individual genetic recombinant line which may exist in a DNA sample derived from genetic recombinants in the sample and for an endogenous DNA sequence shared by the species corresponding to the genetic recombinants using, as a standard molecule, a molecule containing, on a single molecule, the DNA sequence specific to the individual genetic recombinant line and the endogenous DNA sequence; (ii) determining the number of the DNA sequence specific to the individual genetic recombinant line in the sample based on the result of said quantitative PCR; (iii) determining the number of the endogenous DNA sequence in the sample based on the result of the quantitative PCR; and (iv) determining content ratio of the genetic recombinant according to formula (III): (content ratio of the individual genetic recombinant line in the sample)=100×[(the number of molecules or the DNA sequence corresponding to each genetic recombinant in the sample)/(the number of molecules of the endogenous DNA sequence in the sample)]/(quantification ratio)(%) (III) wherein the quantification ratio is any of the values which is pre-calculated according to formula (II): (quantification ratio)(%)=(the number of molecules of the DNA sequence specific to a genetic recombinant from the individual genetic recombinant line)/(the number of molecules of the endogenous DNA sequence in the genetic recombinant) (II).
- 3. The method according to claim 1, wherein the determination of the number of the DNA sequence specific to the genetic recombinant line and the number of the endogenous DNA sequence in the sample comprises
(i) Performing quantitative PCR for the DNA sequence specific to the genetic recombinant line which may exist in the sample and quantitative PCR for the endogenous DNA sequence shared by the species corresponding to the genetic recombinant; and (ii) monitoring a signal which is an indicator of the amplification in the PCR, determining a number of cycles of PCR at which the signal reaches a predefined threshold and then converting the number to a number of molecules which existed at the beginning of the reaction using a standard curve, wherein the standard curve represent a relationship between the number of the DNA sequence to be amplified and the signal which is the indicator of the amplification.
- 4. The method of claim 3, wherein the signal which is the indicator of the amplification is fluorescence, said fluorescence deriving from a fluorescence-labeled probe and said fluorescence being capable of changing depending of the degradation of said probe depending on the amplification of the DNA sequence by the PCR.
- 5. The method of claim 3, wherein the standard curve is obtained by
(a) performing PCR for a standard molecule using primers for amplifying the DNA sequence specific to the genetic recombinant line or the internal DNA sequence shared by the corresponding species to the recombinant under the presence of a probe which increases fluorescent intensity depending on the progress of the amplification of the internal DNA sequence or of the amplification of the DNA sequence specific to the genetic recombinant; (b) monitoring the fluorescence intensity every pre-determined number of times of cycles for each reaction which uses the defined number of the standard molecules as the template DNA which existed at the beginning of the reaction; (c) determining a threshold of fluorescence increase (ΔRn) in the phase where an exponential relationship is observed between fluorescence intensity and the cycle numbers; and (d) plotting a number of PCR cycles reaching the threshold against the number of molecules of the DNA template which existed at the beginning of the reaction by taking the number of PCR cycles as a vertical axis and the number of molecules of the template DNA existing at the beginning of the reaction as a horizontal axis.
- 6. The method according to claim 2, wherein the determination of the number of the DNA sequence specific to the genetic recombinant line and the number of the endogenous DNA sequence in the sample comprises:
(i) Performing quantitative PCR for the DNA sequence specific to the genetic recombinant line which may exist in the sample and quantitative PCR for the endogenous DNA sequence shared by the species corresponding to the genetic recombinant; and (ii) monitoring a signal which is an indicator of the amplification in the PCR, determining a number of cycles of PCR at which the signal reaches a predefined threshold and then converting the number to a number of molecules which existed at the beginning of the reaction using a standard curve, wherein the standard curve represent a relationship between the number of the DNA sequence to be amplified and the signal which is the indicator of the amplification.
- 7. The method of claim 6, wherein the signal which is the indicator of the amplification is fluorescence, said fluorescence deriving from a fluorescence-labeled probe and said fluorescence being capable of changing depending of the degradation of said probe depending on the amplification of the DNA sequence by the PCR.
- 8. The method of claim 6, wherein the standard curve is obtained by
(a) performing PCR for a standard molecule using primers for amplifying the DNA sequence specific to the genetic recombinant line or the internal DNA sequence shared by the corresponding species to the recombinant under the presence of a probe which increases fluorescent intensity depending on the progress of the amplification of the internal DNA sequence or of the amplification of the DNA sequence specific to the genetic recombinant; (b) monitoring the fluorescence intensity every pre-determined number of times of cycles for each reaction which uses the defined number of the standard molecules as the template DNA which existed at the beginning of the reaction; (c) determining a threshold of fluorescence increase (ΔRn) in the phase where an exponential relationship is observed between fluorescence intensity and the cycle numbers; and (d) plotting a number of PCR cycles reaching the threshold against the number of molecules of the DNA template which existed at the beginning of the reaction by taking the number of PCR cycles as a vertical axis and the number of molecules of the template DNA existing at the beginning of the reaction as a horizontal axis.
- 9. A recombinant DNA molecule characterized in that it comprises, on a single molecule, a DNA sequence specific to a line of genetic recombinant(s) and at least one endogenous DNA sequence shared by the species corresponding to the genetic recombinant(s).
- 10. A recombinant DNA molecule characterized in that it comprises, on a single molecule, two or more DNA sequences specific to the individual line of genetic recombinants respectively, and at least one endogenous DNA sequence shared by two or more non-transformants corresponding to said genetic recombinants.
- 11. A recombinant DNA molecule which is capable of self-replicating in a host cell and which comprises the recombinant molecule according to claim 9.
- 12. The recombinant DNA molecule according to claim 11 which is plasmid pMul4 contained in E. coli FERM BP-7319.
- 13. The recombinant DNA molecule according to claim 11 which is plasmid pMul5 contained in E. coli FERM BP-7320.
- 14. The recombinant DNA molecule according to claim 11 which is plasmid pMulSL contained in E. coli FERM BP-7321.
- 15. The recombinant DNA molecule according to claim 11 which is plasmid pMulSL2 contained in E. coli FERM BP-7322.
- 16. A recombinant DNA molecule which is capable of self-replicating in a host cell and which comprises the recombinant molecule according to claim 10.
- 17. The recombinant DNA molecule according to claim 16 which is plasmid pMul4 contained in E. coli FERM BP-7319.
- 18. The recombinant DNA molecule according to claim 16 which is plasmid pMul5 contained in E. coli FERM BP-7320.
- 19. The recombinant DNA molecule according to claim 16 which is plasmid pMulSL contained in E. coli FERM BP-7321.
- 20. The recombinant DNA molecule according to claim 16 which is plasmid pMulSL2 contained in E. coli FERM BP-7322.
- 21. The method of claim 1, wherein the standard molecule is a recombinant DNA molecule characterized in that it comprises, on a single molecule, a DNA sequence specific to a line of genetic recombinant(s) and at least one endogenous DNA sequence shared by the species corresponding to the genetic recombinant(s).
- 22. The method of claim 21, wherein the recombinant DNA molecule is capable of self-replicating in a host cell.
- 23. The method of claim 1, wherein the standard molecule is a recombinant DNA molecule characterized in that it comprises, on a single molecule, two or more DNA sequences specific to the individual line of genetic recombinants respectively, and at least one endogenous DNA sequence shared by two or more non-transformants corresponding to said genetic recombinants.
- 24. The method of claim 23, wherein the recombinant DNA molecule is capable of self-replicating in a host cell.
- 25. The method according to claim 1, wherein a primer comprising the sequence of SEQ ID NO:15 or NO:16 as the 3′-terminal sequence is used.
- 26. The method according to claim 2, wherein a primer comprising the sequence of SEQ ID NO: 15 or NO: 16 as the 3′-terminal sequence is used.
- 27. The method according to claim 1, wherein a primer comprising the sequence of SEQ ID NO: 18 or NO: 19 as the 3′-terminal sequence is used.
- 28. The method according to claim 2, wherein a primer comprising the sequence of SEQ ID NO: 18 or NO: 19 as the 3′-terminal sequence is used.
- 29. The method according to claim 1, wherein a primer comprising the sequence of SEQ ID NO:21 or NO:22 as the 3′-terminal sequence is used.
- 30. The method according to claim 2, wherein a primer comprising the sequence of SEQ ID NO:21 or NO:22 as the 3′-terminal sequence is used.
- 31. The method according to claim 1, wherein a primer comprising the sequence of SEQ ID NO:24 or NO:25 as the 3′-terminal sequence is used.
- 32. The method according to claim 2, wherein a primer comprising the sequence of SEQ ID NO:24 or NO:25 as the 3′-terminal sequence is used.
- 33. The method according to claim 1, wherein a primer comprising the sequence of SEQ ID NO:27 or NO:28 as the 3′-terminal sequence is used.
- 34. The method according to claim 2, wherein a primer comprising the sequence of SEQ ID NO:27 or NO:28 as the 3′-terminal sequence is used.
- 35. The method according to claim 1, wherein a primer comprising the sequence of SEQ ID NO:33 or NO:34 as the 3′-terminal sequence is used.
- 36. The method according to claim 2, wherein a primer comprising the sequence of SEQ ID NO:33 or NO:34 as the 3′-terminal sequence is used.
- 37. The method according to claim 1, wherein a primer comprising the sequence of SEQ ID NO:36 or NO:37 as the 3′-terminal sequence is used.
- 38. The method according to claim 2, wherein a primer comprising the sequence of SEQ ID NO:36 or NO:37 as the 3′-terminal sequence is used.
- 39. The method according to claim 1, wherein a primer comprising the sequence of SEQ ID NO:39 or NO:40 as the 3′-terminal sequence is used.
- 40. The method according to claim 2, wherein a primer comprising the sequence of SEQ ID NO:39 or NO:40 as the 3′-terminal sequence is used.
- 41. The method according to claim 1, wherein a primer comprising the sequence of SEQ ID NO:42 or NO:43 as the 3′-terminal sequence is used.
- 42. The method according to claim 2, wherein a primer comprising the sequence of SEQ ID NO:42 or NO:43 as the 3′-terminal sequence is used.
- 43. The method according to claim 1, wherein a primer comprising the sequence of SEQ ID NO:45 or NO:46 as the 3′-terminal sequence is used.
- 44. The method according to claim 2, wherein a primer comprising the sequence of SEQ ID NO:45 or NO:46 as the 3′-terminal sequence is used.
- 45. The method according to claim 1, wherein a primer comprising the sequence of SEQ ID NO:48 or NO:49 as the 3′-terminal sequence is used.
- 46. The method according to claim 2, wherein a primer comprising the sequence of SEQ ID NO:48 or NO:49 as the 3′-terminal sequence is used.
- 47. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:17 is used.
- 48. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:17 is used.
- 49. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:20 is used.
- 50. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:20 is used.
- 51. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:23 is used.
- 52. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:23 is used.
- 53. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:26 is used.
- 54. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:26 is used.
- 55. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:29 is used.
- 56. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:29 is used.
- 57. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:32 is used.
- 58. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:32 is used.
- 59. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:35 is used.
- 60. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:35 is used.
- 61. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:38 is used.
- 62. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:38 is used.
- 63. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:41 is used.
- 64. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:41 is used.
- 65. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:44 is used.
- 66. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:44 is used.
- 67. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:47 is used.
- 68. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:47 is used.
- 69. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:50 is used.
- 70. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:50 is used.
- 71. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:77 or SEQ ID NO:78 as the 3′-terminal sequence is used.
- 72. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:77 or SEQ ID NO:78 as the 3′-terminal sequence is used.
- 73. The method according to claim 1, wherein a probe comprising the sequence of SEQ ID NO:79 or SEQ ID NO:80 as the 3′-terminal sequence is used.
- 74. The method according to claim 2, wherein a probe comprising the sequence of SEQ ID NO:79 or SEQ ID NO:80 as the 3′-terminal sequence is used.
Priority Claims (1)
Number |
Date |
Country |
Kind |
2000-326738 |
Oct 2000 |
JP |
|
CROSS-REFERENCE TO RELATED APPLICATION
[0001] The present application is a continuation of International Application No. PCT/JP01/09344, which designates the U.S., filed on Oct. 24, 2001, and which claims priority to Japanese Application No. 2000-326738, filed on Oct. 26, 2000.
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/JP01/09344 |
Oct 2001 |
US |
Child |
10423399 |
Apr 2003 |
US |